Application Nr Approved Date Route Status External Links
ANDA091437 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications & Usage To Reduce The Development Of Drug-Resistant Bacteria And Maintain The Effectiveness Of Trimethoprim Tablets, Usp And Other Antibacterial Drugs, Trimethoprim Tablets, Usp Should Be Used Only To Treat Or Prevent Infections That Are Proven Or Strongly Suspected To Be Caused By Susceptible Bacteria. When Culture And Susceptibility Information Are Available, They Should Be Considered In Selecting Or Modifying Antibacterial Therapy. In The Absence Of Such Data, Local Epidemiology And Susceptibility Patterns May Contribute To The Empiric Selection Of Therapy. For The Treatment Of Initial Episodes Of Uncomplicated Urinary Tract Infections Due To Susceptible Strains Of The Following Organisms: Escherichia Coli , Proteus Mirabilis , Klebsiella Pneumoniae , Enterobacter Species, And Coagulase-Negative Staphylococcus Species, Including S. Saprophyticus . Cultures And Susceptibility Tests Should Be Performed To Determine The Susceptibility Of The Bacteria To Trimethoprim. Therapy May Be Initiated Prior To Obtaining The Results Of These Tests.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Trimethoprim TRIMETHOPRIM ZINC6627681

Comments